Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion Using Enoxaparin (ACE) Trial

Circulation - United States
doi 10.1161/01.cir.0000120509.64740.dc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Novel Anticoagulants for Thromboembolic Complications Prevention in Nonvalvular Atrial Fibrillation

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

Efficacy of Novel Oral Anticoagulant Medications for the Prevention of Thromboembolic Complications in Patients With Atrial Fibrillation

Srce i krvni sudovi
2014English

Efficacy and Safety of Oral Anticoagulation in Elderly Patients With Atrial Fibrillation

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2018English

Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin During Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis

BMJ
2012English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Comparison of Atorvastatin and Simvastatin in Prevention of Atrial Fibrillation After Successful Cardioversion

International Heart Journal
MedicineCardiovascular MedicineCardiology
2009English

PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER Study)

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy